An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. (Q37719759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

7

Richard W Price

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

Lars Hagberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

Serena Spudich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

Julia Peterson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

Magnus Gisslen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Wei Shao

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sarah Palmer

series ordinal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

12 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

Journal of Infectious Diseases

3 March 2020

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1618-1622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

Central nervous system compartmentalization of HIV-1 subtype C variants early and late in infection in young children

3 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Central nervous system viral invasion and inflammation during acute HIV infection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

HIV-1 Vif, APOBEC, and intrinsic immunity

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Neurologic complications of HIV disease and their treatment

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3997583

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment

1 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24338353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/INFDIS/JIT805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24338353%20AND%20SRC:MED&resulttype=core&format=json